Skip to main content

Table 3 Difference between CPET2 and CPET1 in patients and controls&

From: Patients with chronic fatigue syndrome performed worse than controls in a controlled repeated exercise study despite a normal oxidative phosphorylation capacity

 

CPET2 minus CPET1

 

Patients n = 15

Controls n = 15

FVC (L)

0.01 ± 0.21

0.05 ± 0.18

FEV 1 (L)

0.00 ± 0.32

0.07 ± 0.17

Rest

Heart rate (beats/min)

1.33 ± 6.29

0.20 ± 6.24

O2 pulse (mL/beat)

-0.17 ± 0.41

0.01 ± 0.47

V'O2/kg [mL/(min.kg)]

-0.07 ± 0.70

-0.07 ± 0.80

Anaerobic Threshold

WR (Watt)

-4.40 ± 9.66

7.67 ± 19.50*

Heart rate (beats/min)

2.60 ± 7.79

4.60 ± 10.16

O2 pulse (ml/beat)

-0.67 ± 0.93

0.25 ± 1.09*

V'O2/kg [mL/(min.kg)]

-0.87 ± 1.77

1.07 ± 2.63*

V'E/V'CO2

-0.21 ± 2.05

-13.8 ± 50.1

Maximal exercise

WR (Watt)

-6.3 ± 11.5

11.1 ± 18.3**

Heart rate (beats/min)

-3.3 ± 8.6

11.9 ± 41.6

O2 pulse (mL/beat)

-0.37 ± 0.70

-4.6 ± 15.0

V'O2/kg [mL/(min.kg)]

-1.33 ± 1.68

0.73 ± 1.39**

  1. & Data are presented as mean ± SD
  2. Differences between patients and controls evaluated by multivariate ANOVA: *: P < 0.05; ** P < 0.01